Jose Tadeu Stefano
Overview
Explore the profile of Jose Tadeu Stefano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Botacin E, Duarte S, Stefano J, Barbosa M, Pessoa M, Oliveira C
Arq Gastroenterol
. 2024 Jul;
61:e23128.
PMID: 39045999
Background: This study aimed to assess the frequency and intensity of anxious and depressive symptoms in patients diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD). Methods: This is a descriptive...
2.
Galvao F, Traldi M, Araujo R, Stefano J, Carneiro DAlbuquerque L, Oliveira C
Arq Gastroenterol
. 2023 Oct;
60(3):383-392.
PMID: 37792769
•In this review, we described different murine models of carcinogenesis: classic models, new transgenic and combined models, that reproduce the key points for HCC and CCA genesis allowing a better...
3.
Nassar-Reis J, Umeta P, Stefano J, Longatto-Filho A, Carrilho F, Alves V, et al.
J Mol Histol
. 2023 Aug;
54(5):473-488.
PMID: 37605073
The efficacy of systemic therapy for hepatocellular carcinoma (HCC) related to non-alcoholic steatohepatitis (NASH) is poorly understood. In this study we evaluated the effects of sorafenib based on the expression...
4.
Yoshimura S, Duarte S, Stefano J, Mazo D, Pinho J, Oliveira C
Arq Gastroenterol
. 2023 May;
60(1):98-105.
PMID: 37194786
Background: Recent studies show an increase in nonalcoholic fatty liver disease (NAFLD) in populations with higher consumption of red meat, processed and cooked at high temperatures. On the other hand,...
5.
Stefano J, Duarte S, Ribeiro Leite Altikes R, Oliveira C
Ther Adv Endocrinol Metab
. 2023 Mar;
14:20420188231160394.
PMID: 36968655
Lifestyle changes should be the main basis for any treatment for metabolic dysfunction-associated fatty liver disease (MAFLD), aiming to increase energy expenditure, reduce energy intake and improve the quality of...
6.
Oliveira C, Paredes A, Siddiqui M, Serfaty L, Chowdhury A, Stefano J, et al.
Hepatoma Res
. 2022 Nov;
6.
PMID: 36419503
Aim: To compare the phenotype of lean versus overweight (OW) and obese (OB) subjects with non-alcoholic fatty liver disease (NAFLD) across multiple continents. Methods: A retrospective study of histologically defined...
7.
Recuero A, Gomes L, Maciel G, de Mello Malta F, Salles A, Vezozzo D, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359239
Background: The aim of this study was to determine the frequency of the rs738409 polymorphism in the patatin-like phospholipase domain containing 3 (PNPLA3) gene in patients with polycystic ovary syndrome...
8.
Duarte S, Stefano J, Franco L, Martins R, Moraes B, Barbeiro D, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142396
Background: Obesity is one of the main health problems in the world today, and dysbiosis seems to be one of the factors involved. The aim of this study was to...
9.
De Souza Melo Alencar R, Oliveira C, Chagas A, da Fonseca L, Maccali C, Saud L, et al.
Clinics (Sao Paulo)
. 2022 Sep;
77:100097.
PMID: 36088887
Objective: The aim of the present study was to evaluate the clinical features, Hepatocellular Carcinoma (HCC) screening, treatment modalities, and Overall Survival (OS) in a series of Non-Alcoholic Fatty Liver...
10.
Cavalcante L, Porto J, Mazo D, Longatto-Filho A, Stefano J, Lyra A, et al.
Ann Hepatol
. 2022 Jun;
27(6):100728.
PMID: 35710086
Introduction And Objectives: PNPLA3 (rs738409) and TM6SF2 (rs58542926) variants, interindividual and ethnic differences may be risk factors for non-alcoholic fatty liver disease (NAFLD). The PNPLA3 G allele is associated with...